Weight loss benefits NASH, no matter how it's done

August 24, 2015
Weight loss benefits NASH, no matter how it's done

(HealthDay)—Weight loss can improve nonalcoholic steatohepatitis (NASH) in obese or overweight people, whether excess pounds are shed through lifestyle changes or weight-loss surgery, according to research published in the August issue of Gastroenterology.

In one study, researchers found that overweight and who achieved a weight loss of 10 percent or more after one year of involving a low-calorie diet and exercise experienced reductions in nonalcoholic fatty liver disease activity score. In addition, 90 percent experience resolution of NASH, and 45 percent showed regression of fibrosis. Weight loss of 7 to 10 percent also reduced disease severity in some patients, including men and those without diabetes.

In the other study, researchers found that NASH disappeared in 85 percent of obese patients one year after they had . The success rate was higher among those with mild NASH (94 percent) than among those with severe disease (70 percent).

"In summary, we have now evidence that weight loss may promote NASH regression, possibly altering the natural history of disease," Giulio Marchesini, M.D., of the University of Bologna, Italy, and colleagues write in an editorial accompanying the studies. "We need to make people more aware of the risks of obesity-associated NASH, and validated weight-reducing strategies should be offered to all patients; behavior therapy, drugs, and surgery should be integrated with each other and with societal interventions, aimed at decreasing the obesiogenic environment. The final recipe is for healthy liver!"

Explore further: Weight loss for a healthy liver

More information: Abstract 1
Full Text
Abstract 2
Full Text
Editorial

Related Stories

Weight loss for a healthy liver

July 27, 2015
Weight loss through both lifestyle modification and bariatric surgery can significantly reduce features of nonalcoholic steatohepatitis (NASH), a disease characterized by fat in the liver, according to two new studies published ...

Drug helps patients with diabetes lose weight

August 18, 2015
Among overweight and obese patients with type 2 diabetes, daily injection of the diabetes drug liraglutide with a modified insulin pen device, in addition to diet and exercise, resulted in greater weight loss over 56 weeks ...

Researchers link liver disease and drug metabolism

July 9, 2015
Researchers at the University of Arizona College of Pharmacy have discovered that nonalcoholic steatohepatitis (NASH), an increasingly common but often undiagnosed liver disease, could have significant medical implications ...

New study indicates that exercise improves non-alcoholic fatty liver disease

April 8, 2015
Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease in the western world. A new study published in the Journal of Hepatology shows that exercise, regardless of frequency or intensity, ...

'Thrifty phenotype' leads to less weight loss in obese

August 1, 2015
(HealthDay)—For obese individuals, energy expenditure during fasting and response to overfeeding predict weight loss in response to caloric restriction, according to a study published in the August issue of Diabetes.

NASH associated with a 50 percent higher chance of death compared with NAFLD

April 24, 2015
Results from a large population-based cohort of almost a million people in the UK found that the chances of dying from non-alcoholic steatohepatitis (NASH), over a 14-year period, was approximately 50% higher than for those ...

Recommended for you

Dengue: Investigating antibodies to identify at-risk individuals

May 23, 2018
Using an original mathematical and statistical analysis method, a team of scientists from the Institut Pasteur partnered with researchers from the United States and Thailand to analyze a Thai cohort that has long been a focus ...

Fatty liver disease research set to benefit from stem cell advance

May 23, 2018
Scientists have developed a lab-based system for studying the most common type of liver disease, paving the way for research into new therapies.

More frequent checks control MRSA in newborns, but can hospitals afford them?

May 22, 2018
The more often a hospital can check its newborns for deadly MRSA germs, the more likely it will be that they are contained, according to a new study.

Could we predict the next Ebola outbreak by tracking the migratory patterns of bats?

May 22, 2018
Javier Buceta, associate professor of bioengineering, Paolo Bocchini, associate professor of civil and environmental engineering, and postdoctoral student Graziano Fiorillo of Lehigh University have created a modeling framework ...

Helping preterm infants grow bigger kidneys would prevent kidney disease later in life

May 21, 2018
Nephrons are the microscopic blood-filtering units inside our kidneys that convert waste products into urine, regulate our electrolyte levels and our blood pressure.

Kidney docs worry over no dialysis for undocumented immigrants

May 21, 2018
(HealthDay)—Undocumented immigrants in the United States are often denied treatment for kidney failure until they have a life-threatening emergency. Now a new study finds that the doctors and nurses who treat them are frustrated ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.